FDA Preemption Policy Driven By Politics, Not Science

From Public Citizen Blog: Rep. Henry Waxman's Oversight and Government Reform Committee, using internal FDA documents, recently issued a devastating report demonstrating that the FDA was driven by political considerations, not science, in seeking preemption of state-law personal-injury claims involving defective and inadequately labeled prescription drugs.